Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions
Small-molecule activation of the TRAIL receptor DR5 in human cancer cells
Smiles: CC1C[C@@]2(N)/C(=C\C)/[C@H](CC3NC(=O)C=CC2=3)C=1
Ubenimex inhibits cell proliferation
-3) tyrosine kinases
Ranolazine dihydrochloride - CAS# 95635-56-6 Size:Solid 10 mg may warrant clinical trials toRanolazine is an anti ischemic compound, which inhibits late sodium current that results in a reduction of Na+ dependent Ca2+ overload. Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine. This is due to the fact that more oxygen is required to phosphorylate the same amount of ATP during fatty acid oxidation than carbohydrate oxidation. These studies indicate that Ranolazine also inhibits oxygen consumption and
US$ 320.00
US$ 85.00
US$ 500.00
US$ 500.00
US$ 3500.00
US$ 1650.00